U.S., Oct. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07848828) titled 'Autonomic and Renal Contributions to Hypertension With ADT' on Sept. 23.
Brief Summary: This study plans to learn more about contributors to high blood pressure in men who undergo androgen deprivation therapy (ADT) to treat prostate cancer. Prostate cancer is the most common non-skin cancer in men, affecting approximately 1 in 8 American men and its primary treatment is through the use of ADT. However, ADT increases the likelihood of developing heart disease including high blood pressure. This study will determine if dysfunction of the nervous system and/or kidneys occurs in men undergoing ADT, as these systems play a significant rol...